Found 1 Presentation For Request "LBA2"

Proffered Paper session Proffered Paper session

LBA2_PR - Phase III PAOLA-1/ENGOT-ov25 trial: Olaparib plus bevacizumab (bev) as maintenance therapy in patients (pts) with newly diagnosed, advanced ovarian cancer (OC) treated with platinum-based chemotherapy (PCh) plus bev (ID 3955)

Presentation Number
LBA2_PR
Lecture Time
16:42 - 16:54
Speakers
  • Isabelle L. Ray-Coquard (Lyon, CEDEX, France)
Location
Barcelona Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
28.09.2019
Time
16:30 - 18:20